HS
JAZZ icon

HighVista Strategies’s Jazz Pharmaceuticals JAZZ Stock Holding History

HighVista Strategies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Buy
+10,838
New +$1.89M 0.57% 58
2019
Q2 		– Sell
-4,700
Closed -$672K – 123
2019
Q1 		$672K Buy
4,700
+3,000
+176% +$391K 0.55% 40
2018
Q4 		$211K Buy
+1,700
New +$252K 0.18% 99

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

HighVista Strategies's JAZZ Position: Q1 2026 in Review

HighVista Strategies opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 10,838 shares worth $2.05M. The stake represents 0.57% of the portfolio and ranks #58 among its holdings. This is a return to the name: HighVista Strategies previously reported a position in JAZZ as recently as Q1 2019.

HighVista Strategies first reported a position in JAZZ in Q4 2018 and has held it in 3 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • HighVista Strategies held 10,838 shares of Jazz Pharmaceuticals worth $2.05M as of Q1 2026.
  • Jazz Pharmaceuticals was a new HighVista Strategies position in Q1 2026.
  • Jazz Pharmaceuticals made up 0.57% of HighVista Strategies's portfolio in Q1 2026, its #58 holding.
  • HighVista Strategies first reported a position in Jazz Pharmaceuticals in Q4 2018 and has held it in 3 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.